7 research outputs found
Identification of a Genetic Factor Required for High γ‑Isoform Concentration in Rice Vitamin E
The
γ-isoforms of tocopherols (Tc) and tocotrienols (T3)
possess high biological activities in comparison to the α-isoforms.
The concentrations of Tc and T3 isoforms in rice (Oriza
sativa) was cultivar-dependent. Using chromosome segment
substitution lines (CSSLs) and near isogenic lines (NILs) of indica cultivar “Kasalath” in a japonica cultivar “Koshihikari” genetic
background, the Kasalath genomic segment on chromosome 2 was determined
to be responsible for the high γ-isoform concentration: γ-tocopherol
methyltransferase (<i>γ-TMT</i>) was identified as
a candidate gene. An amino acid substitution in the coding region
and several nucleotide polymorphisms, including an insertion of 10
base pairs in the promoter region, were identified. Gene expression
analysis revealed that low expression levels of the <i>γ-TMT</i> gene in Kasalath were not associated with the γ-isoform concentration.
Genetic variations in the coding region of the <i>γ-TMT</i> gene may play a major role in determining the γ-isoform concentration.
This information could be used to breed rice with a high γ-isoform
content
α‑Tocopherol Attenuates the Triglyceride- and Cholesterol-Lowering Effects of Rice Bran Tocotrienol in Rats Fed a Western Diet
Previous
studies demonstrated the ability of tocotrienol (T3) to
lower levels of lipids, including cholesterol (Cho) and triglycerides
(TG). Although α-tocopherol (α-Toc) reportedly inhibits
the hypocholesterolemic effect of T3, there is no information about
whether α-Toc influences the TG-lowering effect of T3 in vivo.
In this study, we investigated the influence of α-Toc on the
antihyperlipidemic effects (Cho- and TG-lowering) of rice bran tocotrienols
(RBT3) in F344 rats fed a western diet. α-Toc attenuated both
the Cho- and TG-lowering effects of RBT3 in vivo, whereas α-Toc
alone exhibited no hypolipidemic effects. RBT3-induced <i>Cpt-1a</i> and <i>Cyp7a1</i> gene expression was reduced by α-Toc.
Furthermore, coadministration of α-Toc decreased liver and adipose
tissue concentrations of tocotrienols in F344 rats. These results
indicate that α-Toc has almost no antihyperlipidemic effect
in vivo, but abrogates the antihyperlipidemic effect of RBT3 by reducing
tissue concentrations of tocotrienols and regulating expression of
genes involved in lipid metabolism. Understanding the underlying mechanism
of the beneficial effects of T3 on lipid metabolism and the interaction
with α-Toc will be important for developing T3-based therapeutics
The chromatograms of administration samples.
<p>Aza-sugars in each sample were analyzed using LC-MS/MS.</p
The transition of plasma DNJ concentration.
<p>The rats received orally administered sucrose (2 g/kg B.W.) 15 minutes after each samples administration (equivalent to 5 mg DNJ or miglitol/kg B.W.). Blood was collected from tail venous vein and plasma DNJ or miglitol concentration was determined using LC-MS/MS. Results are given as means ± SE. Means without a common letter differ significantly (p < 0.05).</p
The recovery rate of <sup>15</sup>N from DNJ in urine and feces until 48 hours after sample administration.
<p>The recovery rate of <sup>15</sup>N from DNJ in urine and feces until 48 hours after sample administration. After 12 hours fasting, the rats were received <sup>15</sup>N-labeled DNJ (10 mg). Urine and feces were collected and the amount of <sup>15</sup>N from DNJ was analyzed. (a) The time course of recovery rate of <sup>15</sup>N in urine. (b) Total recovery rate of <sup>15</sup>N in urine and feces. Results are given as means ± SE.</p
The effects in suppressing the blood glucose in rats.
<p>The rats received orally administered sucrose (2 g/kg B.W.) 15 minutes after each samples administration (equivalent to 5 mg DNJ or miglitol/kg B.W.). Blood glucose levels were determined from tail blood sample. (a) is the transition of blood glucose concentration and (b) is area of under curve of blood glucose concentration. Results are given as means ± SE. * p < 0.05 versus control; ** p < 0.01 versus control.</p
The aza-sugars composition of administration samples.
<p>The aza-sugars composition of administration samples.</p